A Logic-Based Framework Leveraging Neural Networks for Studying the Evolution of Neurological Disorders
Calimeri, F., Cauteruccio, F., Cinelli, L., Marzullo, A., Stamile, C., Terracina, G., Durand-Dubief, F., and Sappey-Marinier, D. (2019). Theory and Practice of Logic Programming p.1–45
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Cobo-Calvo, A., Sepúlveda, M., Rollot, F., Armangué, T., Ruiz, A., Maillart, E., Papeix, C., Audoin, B., Zephir, H., Biotti, D., et al. (2019a). J Neuroinflammation (16). p.134
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions
Ayrignac, X., Rigau, V., Lhermitte, B., Vincent, T., de Champfleur, N.M., Carra-Dalliere, C., Charif, M., Collongues, N., de Seze, J., Hebbadj, S., et al. (2019). J. Neurol. (266). p.1743–1755
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Ciron, J., Cobo-Calvo, A., Audoin, B., Bourre, B., Brassat, D., Cohen, M., Collongues, N., Deschamps, R., Durand-Dubief, F., Laplaud, D., et al. (2019). Mult. Scler. p.1352458519849511
Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease
Ameli, R., R G Guttmann, C., Prieto, J.C., Rollot, F., Palotai, M., Vukusic, S., Marignier, R., Cotton, F., and Group Members for OFSEP Imaging Working, COPIL of OFSEP, the NOMADMUS study group. (2019). J Neuroradiol
Caractéristique de la cohorte française des pré syndromes radiologiques isolés (PRE RIS)
Callier, C., Vermersch, P., Durand-Dubief, F., Carra-Dallière, C., Wiertlewski, S., Mondot, L., and Lebrun-Frenay, C. (2019). Revue Neurologique (175). p.S85
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Cobo-Calvo, A., Sepúlveda, M., d’Indy, H., Armangué, T., Ruiz, A., Maillart, E., Papeix, C., Audoin, B., Zephir, H., Biotti, D., et al. (2019b). J. Neurol. (266). p.806–815
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Cobo-Calvo, A., Sepúlveda, M., d’Indy, H., Armangué, T., Ruiz, A., Maillart, E., Papeix, C., Audoin, B., Zephir, H., Biotti, D., et al. (2019c). J. Neurol. (266). p.816
Spatial distribution of multiple sclerosis lesions in the cervical spinal cord
Eden, D., Gros, C., Badji, A., Dupont, S.M., De Leener, B., Maranzano, J., Zhuoquiong, R., Liu, Y., Granberg, T., Ouellette, R., et al. (2019). Brain (142). p.633–646
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brassat, D., Brenton, J.N., Cabre, P., Carra Dallière, C., de Seze, J., et al. (2019a). Mult Scler J Exp Transl Clin (5). p.2055217319836664
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brassat, D., Brenton, J.N., Cabre, P., Carra Dallière, C., de Seze, J., et al. (2019b). Mult Scler J Exp Transl Clin (5). p.2055217319836664
Cranial nerve involvement in patients with MOG antibody–associated disease
Cobo-Calvo, A., Ayrignac, X., Kerschen, P., Horellou, P., Cotton, F., Labauge, P., Vukusic, S., Deiva, K., Serguera, C., and Marignier, R. (2019d). Neurol Neuroimmunol Neuroinflamm (6).
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases
Codjia, P., Ayrignac, X., Carra-Dalliere, C., Cohen, M., Charif, M., Lippi, A., Collongues, N., Corti, L., De Seze, J., Lebrun, C., et al. (2019). Mult Scler Relat Disord (28). p.109–116
First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study
Lavandier, N., Bonnan, M., Carra-Dallière, C., Charif, M., Labauge, P., Camdessanche, J.-P., Edan, G., Naudin, A., Brassat, D., Ciron, J., et al. (2019). Mult Scler Relat Disord (28). p.309–312
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis]
Zephir, H., Puyade, M., Gueguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P., Marjanovic, Z., et al. (2019). Bull Cancer (106). p.S92–S101
Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults
Cobo-Calvo, A., Vukusic, S., and Marignier, R. (2019e). Curr. Opin. Neurol. (32). p.459–466
Myelin oligodendrocyte glycoprotein antibody associated disease: about the importance of diagnostic assays and selection of the target population in retrospective studies
Cobo-Calvo, A., Ruiz, A., and Marignier, R. (2019f). Eur. J. Neurol. (26). p.e58–e59
Efficacy of rituximab in refractory RRMS
Durozard, P., Maarouf, A., Boutiere, C., Ruet, A., Brochet, B., Vukusic, S., Carra-Dalliere, C., Labauge, P., Mathey, G., Debouverie, M., et al. (2019). Mult. Scler. (25). p.828–836
Multiple sclerosis registries in Europe - An updated mapping survey
Glaser, A., Stahmann, A., Meissner, T., Flachenecker, P., Horáková, D., Zaratin, P., Brichetto, G., Pugliatti, M., Rienhoff, O., Vukusic, S., et al. (2019). Mult Scler Relat Disord (27). p.171–178
Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks
Gros, C., De Leener, B., Badji, A., Maranzano, J., Eden, D., Dupont, S.M., Talbott, J., Zhuoquiong, R., Liu, Y., Granberg, T., et al. (2019). Neuroimage (184). p.901–915
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium (2019a). Science (365).
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium (2019b). Science (365).
Multiple sclerosis: effect of beta interferon treatment on survival
Kingwell, E., Leray, E., Zhu, F., Petkau, J., Edan, G., Oger, J., and Tremlett, H. (2019). Brain (142). p.1324–1333
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
Laplaud, D.-A., Casey, R., Barbin, L., Debouverie, M., De Sèze, J., Brassat, D., Wiertlewski, S., Brochet, B., Pelletier, J., Vermersch, P., et al. (2019). Neurology (93). p.e635–e646
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Lavie, C., Rollot, F., Durand-Dubief, F., Marignier, R., Ionescu, I., Casey, R., Moreau, T., Tourniaire, P., Hutchinson, M., D’Hooghe, M.B., et al. (2019). Mult. Scler. (25). p.591–600
Classification of Multiple Sclerosis Clinical Profiles via Graph Convolutional Neural Networks
Marzullo, A., Kocevar, G., Stamile, C., Durand-Dubief, F., Terracina, G., Calimeri, F., and Sappey-Marinier, D. (2019). Front Neurosci (13). p.594
The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab
Nicolas, P., Ruiz, A., Cobo-Calvo, A., Fiard, G., Giraudon, P., Vukusic, S., and Marignier, R. (2019). Front Immunol (10). p.2686